Selected Disorders of Malabsorption

Primary Care - Clinics in Office Practice

Volumn 38, Issue 3, 2011, Pages 395-414

  Siddiqui, Zafreen ^a   Osayande, Amimi S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Celiac; Lactase deficiency; Lactose intolerance; Pernicious anemia; Sprue; Vitamin B 12

Indexed keywords

CORTICOSTEROID; CYANOCOBALAMIN; HYDROCORTISONE; LOPERAMIDE; PREDNISONE; PROPANTHELINE BROMIDE;

BLOOD EXAMINATION; CELIAC DISEASE; CELLULAR IMMUNITY; CLINICAL FEATURE; CONGENITAL LACTASE DEFICIENCY; DIGESTIVE FUNCTION; DRUG DOSE REDUCTION; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC ASSOCIATION; GLUTEN FREE DIET; HEADACHE; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; INTESTINE MUCOSA; INTESTINE RADIOGRAPHY; LACTASE DEFICIENCY; LACTOSE INTOLERANCE; MALABSORPTION; NAUSEA; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT REFERRAL; PERNICIOUS ANEMIA; PHYSICAL EXAMINATION; PRIMARY LACTASE DEFICIENCY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REVIEW; RHINITIS; SECONDARY LACTASE DEFICIENCY; SKIN EXAMINATION; TREATMENT PLANNING; VITAMIN SUPPLEMENTATION;

ANEMIA, PERNICIOUS; CELIAC DISEASE; COLON; ENVIRONMENT; HUMANS; LACTASE; MALABSORPTION SYNDROMES; PHYSICAL EXAMINATION; RISK FACTORS;

EID: 80052351165     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2011.05.002     Document Type: Review

References (102)

1. Farrell R.J., Kelly C.P. Celiac sprue. N Engl J Med 2002, 346(3):180-188.
2. Venes D, Taber CW, editors. Taber's cyclopedic medical dictionary. 21st edition. Illustrated in full color. Philadelphia: F. A. Davis Co; 2009.
3. Hadjivassiliou M., Grunewald R.A., Davies-Jones G.A. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999, 67(2):257.
4. Kagnoff M.F., Austin R.K., Hubert J.J., et al. Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 1984, 160(5):1544-1557.
5. Sanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358(9292):1504-1508.
6. Barera G., Bonfanti R., Viscardi M., et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002, 109(5):833-838.
7. Lo Iacono O., Petta S., Venezia G., et al. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?. Am J Gastroenterol 2005, 100(11):2472-2477.
8. Norris J.M., Barriga K., Hoffenberg E.J., et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005, 293(19):2343-2351.
9. Feighery C. Fortnightly review: coeliac disease. BMJ 1999, 319(7204):236-239.
10. Hankey G.L., Holmes G.K. Coeliac disease in the elderly. Gut 1994, 35(1):65-67.
11. Ciacci C., Cirillo M., Sollazzo R., et al. Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol 1995, 30(11):1077-1081.
12. Dube C., Rostom A., Sy R., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterolog 2005, 128(4 Suppl 1):S57-S67.
13. McGowan K.E., Castiglione D.A., Butzner J.D. The changing face of childhood celiac disease in north america: impact of serological testing. Pediatrics 2009, 124(6):1572-1578.
14. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163(3):286-292.
15. Pietzak M.M., Schofield T.C., McGinniss M.J., et al. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol 2009, 7(9):966-971.
16. Petronzelli F., Bonamico M., Ferrante P., et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997, 61(Pt 4):307-317.
17. Pittschieler K., Ladinser B. Coeliac disease: screened by a new strategy. Acta Paediatr Suppl 1996, 412:42-45.
18. Vader W., Kooy Y., Van Veelen P., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002, 122(7):1729-1737.
19. Esposito C., Paparo F., Caputo I., et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002, 51(2):177-181.
20. Maki M., Mustalahti K., Kokkonen J., et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003, 348(25):2517-2524.
21. Matysiak-Budnik T., Candalh C., Dugave C., et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003, 125(3):696-707.
22. Lammers K.M., Lu R., Brownley J., et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008, 135(1):194-204. e193.
23. Maiuri L., Ciacci C., Ricciardelli I., et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362(9377):30-37.
24. Sanders D.S., Hopper A.D., Azmy I.A., et al. Association of adult celiac disease with surgical abdominal pain: a case-control study in patients referred to secondary care. Ann Surg 2005, 242(2):201-207.
25. McPhee SJ., Papadakis MA. Current medical diagnosis & treatment 2010 2010, London, McGraw-Hill Medical, New York. 49th edition.
26. Furse R.M., Mee A.S. Atypical presentation of coeliac disease. BMJ 2005, 330(7494):773-774.
27. Seyhan M., Erdem T., Ertekin V., et al. The mucocutaneous manifestations associated with celiac disease in childhood and adolescence. Pediatr Dermatol 2007, 24(1):28-33.
28. Aine L., Maki M., Collin P., et al. Dental enamel defects in celiac disease. J Oral Pathol Med 1990, 19(6):241-245.
29. Hu W.T., Murray J.A., Greenaway M.C., et al. Cognitive impairment and celiac disease. Arch Neurol 2006, 63(10):1440-1446.
30. Lionetti E., Francavilla R., Maiuri L., et al. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr 2009, 49(2):202-207.
31. Zelnik N., Pacht A., Obeid R., et al. Range of neurologic disorders in patients with celiac disease. Pediatrics 2004, 113(6):1672-1676.
32. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006, 131(6):1977-1980. AGA Institute.
33. Hill I.D., Dirks M.H., Liptak G.S., et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005, 40(1):1-19.
34. Lewis N.R., Scott B.B. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006, 24(1):47-54.
35. Kwiecien J., Karczewska K., Lukasik M., et al. Negative results of antiendomysial antibodies: long term follow up. Arch Dis Child 2005, 90(1):41-42.
36. Kelly C.P., Feighery C.F., Gallagher R.B., et al. Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci 1991, 36(6):743-751.
37. Uibo O., Uibo R., Kleimola V., et al. Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci 1993, 38(11):2034-2037.
38. Fotoulaki M., Nousia-Arvanitakis S., Augoustidou-Savvopoulou P., et al. Clinical application of immunological markers as monitoring tests in celiac disease. Dig Dis Sci 1999, 44(10):2133-2138.
39. Nemec G., Ventura A., Stefano M., et al. Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol 2006, 101(7):1597-1600.
40. Hadithi M., von Blomberg B.M., Crusius J.B., et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007, 147(5):294-302.
41. Russo P.A., Chartrand L.J., Seidman E. Comparative analysis of serologic screening tests for the initial diagnosis of celiac disease. Pediatrics 1999, 104(1 Pt 1):75-78.
42. Cataldo F., Marino V., Bottaro G., et al. Celiac disease and selective immunoglobulin A deficiency. J Pediatr 1997, 131(2):306-308.
43. Ackerman Z., Eliakim R., Stalnikowicz R., et al. Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anemia. Am J Gastroenterol 1996, 91(10):2099-2102.
44. Uil J.J., van Elburg R.M., Mulder C.J., et al. The value of the D-xylose test compared with the differential sugar absorption test in recognizing coeliac disease. Neth J Med 1996, 49(2):68-72.
45. Kelly C.P., Feighery C.F., Gallagher R.B., et al. Diagnosis and treatment of gluten-sensitive enteropathy. Adv Intern Med 1990, 35:341-363.
46. Rubesin S.E., Herlinger H., Saul S.H., et al. Adult celiac disease and its complications. Radiographics 1989, 9(6):1045-1066.
47. Jarvinen T.T., Collin P., Rasmussen M., et al. Villous tip intraepithelial lymphocytes as markers of early-stage coeliac disease. Scand J Gastroenterol 2004, 39(5):428-433.
48. Trier J.S. Diagnosis of celiac sprue. Gastroenterology 1998, 115(1):211-216.
49. Akobeng A.K., Thomas A.G. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 2008, 27(11):1044-1052.
50. Fabiani E., Catassi C. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol 2001, 13(6):659-665.
51. Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995, 333(16):1033-1037.
52. Hogberg L., Laurin P., Falth-Magnusson K., et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004, 53(5):649-654.
53. Kaukinen K., Salmi T., Collin P., et al. Clinical trial: gluten microchallenge with wheat-based starch hydrolysates in coeliac disease patients - a randomized, double-blind, placebo-controlled study to evaluate safety. Aliment Pharmacol Ther 2008, 28(10):1240-1248.
54. Lundin K.E., Nilsen E.M., Scott H.G., et al. Oats induced villous atrophy in coeliac disease. Gut 2003, 52(11):1649-1652.
55. Shaker J.L., Brickner R.C., Findling J.W., et al. Hypocalcemia and skeletal disease as presenting features of celiac disease. Arch Intern Med 1997, 157(9):1013-1016.
56. Meyer D., Stavropolous S., Diamond B., et al. Osteoporosis in a north american adult population with celiac disease. Am J Gastroenterol 2001, 96(1):112-119.
57. Scott E.M., Gaywood I., Scott B.B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000, 46(Suppl 1):i1-i8.
58. Pink I.J., Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967, 1(7485):300-304.
59. Macdonald W.C., Brandborg L.L., Flick A.L., et al. Studies of Celiac Sprue. Iv. The Response of the Whole Length of the Small Bowel to a Gluten-Free Diet. Gastroenterology 1964, 47:573-589.
60. Selby P.L., Davies M., Adams J.E., et al. Bone loss in celiac disease is related to secondary hyperparathyroidism. J Bone Miner Res 1999, 14(4):652-657.
61. Carroccio A., Iacono G., Lerro P., et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology 1997, 112(6):1839-1844.
62. Trier J.S., Falchuk Z.M., Carey M.C., et al. Celiac sprue and refractory sprue. Gastroenterology 1978, 75(2):307-316.
63. Ryan B.M., Kelleher D. Refractory celiac disease. Gastroenterology 2000, 119(1):243-251.
64. Bagdi E., Diss T.C., Munson P., et al. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999, 94(1):260-264.
65. Gao Y., Kristinsson S.Y., Goldin L.R., et al. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology 2009, 136(1):91-98.
66. Baker A.L., Rosenberg I.H. Refractory sprue: recovery after removal of nongluten dietary proteins. Ann Intern Med 1978, 89(4):505-508.
67. Maurino E., Niveloni S., Chernavsky A., et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002, 97(10):2595-2602.
68. Daum S., Ipczynski R., Heine B., et al. Therapy with budesonide in patients with refractory sprue. Digestion 2006, 73(1):60-68.
69. Wahab P.J., Crusius J.B., Meijer J.W., et al. Cyclosporin in the treatment of adults with refractory coeliac disease-an open pilot study. Aliment Pharmacol Ther 2000, 14(6):767-774.
70. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999, 117(2):297-303.
71. Norgard B., Fonager K., Sorensen H.T., et al. Birth outcomes of women with celiac disease: a nationwide historical cohort study. Am J Gastroenterol 1999, 94(9):2435-2440.
72. Coeliac disease: recognition and assessment of coeliac disease Available at:, Accessed August 16, 2010. http://www.nice.org.uk/nicemedia/pdf/CG86FullGuideline.pdf.
73. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996, 156(10):1097-1100.
74. Green R., Kinsella L.J. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995, 45(8):1435-1440.
75. Centanni M., Marignani M., Gargano L., et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 1999, 159(15):1726-1730.
76. Pruthi R.K., Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994, 69(2):144-150.
77. Campbell N.R. How safe are folic acid supplements?. Arch Intern Med 1996, 156(15):1638-1644.
78. Toh B.H., van Driel I.R., Gleeson P.A. Pernicious anemia. N Engl J Med 1997, 337(20):1441-1448.
79. Dang C.V. Runner's anemia. JAMA 2001, 286(6):714-716.
80. Lahner E., Norman G.L., Severi C., et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 2009, 104(8):2071-2079.
81. Lindgren A., Bagge E., Cederblad A., et al. Schilling and protein-bound cobalamin absorption tests are poor instruments for diagnosing cobalamin malabsorption. J Intern Med 1997, 241(6):477-484.
82. Berlin H., Berlin R., Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand 1968, 184(4):247-258.
83. Slot W.B., Merkus F.W., Van Deventer S.J., et al. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Gastroenterology 1997, 113(2):430-433.
84. Elia M. Oral or parenteral therapy for B12 deficiency. Lancet 1998, 352(9142):1721-1722.
85. Delpre G., Stark P., Niv Y. Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet 1999, 354(9180):740-741.
86. Hsing A.W., Hansson L.E., McLaughlin J.K., et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993, 71(3):745-750.
87. Brinton L.A., Gridley G., Hrubec Z., et al. Cancer risk following pernicious anaemia. Br J Cancer 1989, 59(5):810-813.
88. Hirota W.K., Zuckerman M.J., Adler D.G., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006, 63(4):570-580.
89. Sibley E., Fisher R., Pennington J. Lactose intolerance Available at:, Accessed May 5, 2010. http://digestive.niddk.nih.gov/ddiseases/pubs/lactoseintolerance/.
90. Swagerty D.L., Walling A.D., Klein R.M. Lactose intolerance. Am Fam Physician 2002, 65(9):1845-1850.
91. Asp N.G., Dahlqvist A., Kuitunen P., et al. Complete deficiency of brush-border lactase in congenital lactose malabsorption. Lancet 1973, 2(7824):329-330.
92. Freiburghaus A.U., Schmitz J., Schindler M., et al. Protein patterns of brush-border fragments in congenital lactose malabsorption and in specific hypolactasia of the adult. N Engl J Med 1976, 294(19):1030-1032.
93. Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol Suppl 1994, 202:26-35.
94. Heyman M.B. Lactose intolerance in infants, children, and adolescents. Pediatrics 2006, 118(3):1279-1286.
95. Reasoner J., Maculan T.P., Rand A.G., et al. Clinical studies with low-lactose milk. Am J Clin Nutr 1981, 34(1):54-60.
96. Martini M.C., Savaiano D.A. Reduced intolerance symptoms from lactose consumed during a meal. Am J Clin Nutr 1988, 47(1):57-60.
97. Lin M.Y., Yen C.L., Chen S.H. Management of lactose maldigestion by consuming milk containing lactobacilli. Dig Dis Sci 1998, 43(1):133-137.
98. Szilagyi A., Torchinsky A., Calacone A. Possible therapeutic use of loperamide for symptoms of lactose intolerance. Can J Gastroenterol 2000, 14(7):581-587.
99. Peuhkuri K., Vapaatalo H., Nevala R., et al. Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms. Aliment Pharmacol Ther 1999, 13(1):81-86.
100. Medow M.S., Thek K.D., Newman L.J., et al. Beta-galactosidase tablets in the treatment of lactose intolerance in pediatrics. Am J Dis Child 1990, 144(11):1261-1264.
101. Sanders M.E., Klaenhammer T.R. Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001, 84(2):319-331.
102. Hertzler S.R., Savaiano D.A. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 1996, 64(2):232-236.